Nomic Bio YC Application
Nomic Bio went through Y Combinator in the Winter 2020 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Winter 2020
- Industry
- HealthcareDiagnostics
- Team size
- 24
- Status
- Active
- Launched
- 2020
Founders
Milad DagherFounder
Jeff MunzarFounder
What Nomic Bio does
Nomic is doing for protein profiling, what Illumina did for DNA sequencing. Our core technology, the nELISA, is a next-gen immunoassay platform that transforms the ELISA into a high-throughput, high-content, and high-versatility tool. Today we developed the nELISA for high-throughput drug discovery scientists, enabling them profile 100s of proteins at 10x higher throughput and 10x lower cost compared to existing solutions. We're offering the nELISA through early access programs to HTS groups in top pharmas as well as pioneering biotechs in the space. Our goal is to create a ubiquitous technology that consolidates the broad range of legacy immunoassay toolkits that scientists use today with a single platform that can carry the science end-to-end, from discovery all the way to the clinic. We're a team of engineers, biologists, and highly-skilled lab operators that are looking to grow quickly to keep up with customer demand but also to continue developing our core technology, scale our multiplexing/throughput, and build our software stack. We're hiring on a number of positions including engineering, software, biology, and ops. Come talk to us!
Nomic Bio's YC application, reconstructed
Y Combinator application
Nomic Bio, Winter 2020 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Nomic Bio
Protein profiling like Illumina did for DNA
We built the nELISA, a next-generation immunoassay platform that lets drug discovery scientists profile hundreds of proteins simultaneously with 10x higher throughput and 10x lower cost than current solutions. Unlike legacy ELISA kits, our platform scales high-content protein measurement for early discovery through to clinical use, consolidating multiple assay types into one versatile tool.
We live in Montreal, QC, Canada, and plan to keep the company based here after YC.
Montreal has the local expertise in biochemistry, engineering, and nanotech that our platform requires. It also offers a strong, low-cost talent pool compared to typical US hubs and aligns with the founders' personal ties and initial lab setup.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real Nomic Bio YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Nomic Bio's public data (launch notes, founder backgrounds, product description). It shows how a company like Nomic Bio would present itself to YC, not the text they submitted.
What YC batch was Nomic Bio in?
Nomic Bio was part of the Y Combinator Winter 2020 batch.
Who founded Nomic Bio?
Nomic Bio was founded by Milad Dagher, Jeff Munzar.
What does Nomic Bio do?
Nomic is doing for proteins what Illumina has done for DNA
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of Nomic Bio's application, and every other YC batch, is in YC Insights.
More YC startups like Nomic Bio
